2013 has presented a unique set of challenges to the pharmaceutical industry. Transparency is becoming ever more prevalent in all aspects of the regulatory process, regulatory bodies are sanctioning drug companies unlike ever before, competitors are using new strategies to gain possession of your best-kept secrets, the impact of technology continues to grow, and new legislation is coming into force which will alter the playing field for everyone. C5's EU Pharma Regulatory Law conference will focus on the practical solutions to the current challenges facing pharma companies, legal practitioners, and regulatory and compliance officers. You will hear the specific strategies used by industry experts in dealing with regulatory challenges in 2013, which will impact your company in 2014 and beyond.
Gain insights from the legal opinions of key European and government regulators; hear cutting edge case studies from the lawyers involved; get up-to-date information on the critical issues that will enable your company to maximise profits by avoiding harsh sanctions.
By attending this event and hearing from the top experts in this field, you will acquire the best strategies to:
- Deal effectively with the transparency inherent in the forthcoming clinical trials data requirements, protecting your competitive commercial knowledge without running afoul of the new requirements.
- Safeguard your confidential business information contained in the medical authorisation dossier from your competitors.
- Avoid the harsh pharmacovigilance sanctions recently sought by the EMA under the financial penalties legislation.
- Ensure that your competitive strategies, including use of the patent scheme will not subject your company to sanctions.
- Guarantee compliance with all new revisions to regulatory law, including API legislation, the medical device recast, the revisions to the EFPIA advertising code, and recent cases on the CJEU and cases and inquiries on the EU member state level.
- Utilise digital technologies to the benefit of your company, and ensure compliance with the specific concerns surrounding Health Technology Assessments, E-health, and social media.
- Surmount new reimbursement and pricing limitations that have severely impacted profitability.
Get the best return on your company's investment. Learn the best strategies to navigate through the current challenges in pharma regulation. Don't miss out on this unique opportunity.
For furher information and registration, please visit:
http://www.c5-online.com/2014/589/8th-eu-pharma-regulatory-law/overview
About C5
For over a decade, events produced by C5 have offered interactive, topical and business critical forums across a multitude of industries around the world. Forums are meticulously written to deliver the tools required by industry leaders, corporate decision-makers and legal experts to respond to the on-going challenges whilst capitalising on available business opportunities.
A unique organisation, C5 is staffed by industry and country specialists; lawyers and other professionals. We operate as a think tank, monitoring trends and developments in all major industry sectors, the law and high growth markets, with a view to providing up to date and comprehensive business information.
Based in the heart of central London, C5 holds conferences across the globe and has grown to produce over 90 market leading events a year, attended by thousands of senior delegates from all over the world.